München Klinik Harlaching ( Site 0351)

Munich, Bavaria 81545

0 studies enrolling now · 1 studies all time

What they study most

RSV Infection

Studies at this site

• Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) — Completed